Studies: Inflammation-targeting antibody boosts preterm birth outcomes, prevents obesity-linked liver disease
June 23, 2023
JUPITER, Fla. 鈥� Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions with limited treatment鈥�
The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
